| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |